IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

91 hedge funds and large institutions have $323M invested in Insight Molecular Diagnostics Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 11 closing their positions.

Holders
91
Holders Change
+3
Holders Change %
+3.41%
% of All Funds
1.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
26
Reduced
34
Closed
11
Calls
$1.31M
Puts
$607K
Net Calls
+$700K
Net Calls Change
-$2K

Top Buyers

1
DC
1
Defender Capital
North Carolina
$7.73M
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$8.39M
3
PGM
3
Parian Global Management
New York
$6M
4
MS
4
Maven Securities
Jersey
$2.73M
5
Goldman Sachs
5
Goldman Sachs
New York
$2.2M

Top Sellers

1
SCM
1
Soleus Capital Management
Connecticut
$0
2
BlackRock
2
BlackRock
New York
$27.1M
3
SSA
3
Schonfeld Strategic Advisors
New York
$7.97M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$796K
5
Barclays
5
Barclays
United Kingdom
$58K
Name Market Value Shares Shares
Change 		Shares
Change %
PHK
101
Point72 Hong Kong
Hong Kong
– – -5 Closed
IA
102
IFP Advisors
Florida
– – – –
HT
103
HAP Trading
New York
– – – –
CFGS
104
Concourse Financial Group Securities
Alabama
– – – –
IHWM
105
Iron Horse Wealth Management
Iowa
– – – –
1 2 3 4
5